In severe asthma, more exacerbations occur November through January, with respiratory infection as the most commonly identified trigger.
Dupilumab significantly reduced the risk of exacerbations compared with placebo in children with moderate to severe asthma, regardless of exacerbation history. Dupilumab was shown to consistently ...
In patients with moderate-to-severe allergic asthma, tezepelumab yields the greatest reduction in exacerbations among ...
asian child girl patient receiving artificial ventilation in hospital To address the void in data on ventilation trends among children with asthma, investigators analyzed data from the largest US ...
Depemokimab significantly reduces asthma exacerbations, showing similar efficacy in both controlled and uncontrolled asthma patients. The study included patients with eosinophilic asthma using medium- ...
About 30 to 40% of children with asthma experience sleep difficulties due to symptoms like coughing and wheezing. Poor sleep ...
The following article is a part of conference coverage from the American Academy of Allergy, Asthma & Immunology Annual Meeting, being held in Phoenix, Arizona, from February 25 to 28, 2022. Click ...
—Researchers from Australia conducted a year-round study to investigate the impacts of different pollen types on asthma exacerbations in both children and adults. Population studies in children and ...
Fixed airway obstruction in severe asthma shows distinct clinical and biological traits, with some patients improving over ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback